BerandaHXB • FRA
add
AIM ImmunoTech Inc
Tutup sebelumnya
€6,10
Rentang tahun
€6,10 - €22,00
Kapitalisasi pasar
3,97 jt USD
Rasio P/E
-
Hasil dividen
-
Berita pasar
Tirto.id
18 jam yang lalu
NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE
2,08%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 21,00 rb | -53,33% |
Biaya operasional | 2,93 jt | -50,23% |
Penghasilan bersih | -4,18 jt | 30,03% |
Margin laba bersih | -19,88 rb | -49,93% |
Penghasilan per saham | -0,44 | 95,60% |
EBITDA | -2,91 jt | 49,77% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,05 jt | -23,38% |
Total aset | 5,78 jt | -32,83% |
Total liabilitas | 15,56 jt | 56,75% |
Total ekuitas | -9,78 jt | — |
Saham yang beredar | 8,15 jt | — |
Harga terhadap nilai buku | -1,91 | — |
Tingkat pengembalian aset | -130,90% | — |
Tingkat pengembalian modal | 171,11% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -4,18 jt | 30,03% |
Kas dari operasi | -1,99 jt | 49,79% |
Kas dari investasi | -95,00 rb | -102,56% |
Kas dari pembiayaan | 2,72 jt | 162,20% |
Perubahan kas bersih | 638,00 rb | -18,83% |
Arus kas bebas | -1,43 jt | 74,40% |
Tentang
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Didirikan
1966
Kantor pusat
Situs
Karyawan
20
